The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy.
There are no risks for the patients, as this is a retrospective data collection.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Diagnosis of clinical or pathological stage IIB (T1-2, hilar N1, M0) and III (any T, N1-2, M0) NSCLC surgically treated with robotic, VATS and open approach with radical intent from 1st of January 2016 to 31st of March 2024
* Received neoadjuvant chemo-immunotherapy or immunotherapy alone
* Age \>= 18 years old at the moment of surgery
Exclusion Criteria:
* Age \<18 years old at the moment of surgery
Primary outcome measure(s)
The perioperative complication of video-assisted thoracoscopic surgery (VATS) approach — 30-90 days after surgery The investigators will measure the perioperative complications of VATS approach in patients who received neoadjuvant chemo-immunotherapy. Complications will be categorized according to the Clavien-Dindo scale.
The perioperative complications of robotic approach — from the surgery at 30-90 days after The investigators will measure the perioperative complications of robotic lung resection in patients who received neoadjuvant chemo-immunotherapy. Complications will be categorized according to the Clavien-Dindo scale.
The perioperative complications of the open approach — 30-90 days after surgery The investigators will measure the perioperative complications of open approach in patients who received neoadjuvant chemo-immunotherapy. Complications will be categorized according to the Clavien-Dindo scale.
Trial sites (6)
Facility
City
Region
Status
Baptist Health South Florida
Miami
Florida
Recruiting
Memorial Sloan Kettering Cancer Center
New York
New York
Recruiting
West Virginia University
Morgantown
West Virginia
Recruiting
Istituto Clinico Humanitas
Rozzano
Milan
Recruiting
Scientific Institute Ospedale San Raffaele
Milan
Italy
Recruiting
Regina Elena National Cancer Institute
Rome
Italy
Recruiting
More Scientific Institute San Raffaele trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
